Successful Treatment of Acyclovir-Resistant Herpes Simplex Virus With Intralesional Cidofovir
Open Access
- 1 February 2010
- journal article
- case report
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 146 (2) , 124-126
- https://doi.org/10.1001/archdermatol.2009.363
Abstract
Acyclovir-resistant herpes simplex virus (HSV) has become increasingly common, particularly among patients with human immunodeficiency virus (HIV). We present aKeywords
This publication has 12 references indexed in Scilit:
- Intralesional cidofovir does not increase the risk of laryngeal dysplasia or laryngeal carcinomaInternational Journal of Pediatric Otorhinolaryngology, 2008
- Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosisEuropean Archives of Oto-Rhino-Laryngology, 2008
- Cidofovir: to use or not to use?Current Opinion in Otolaryngology & Head and Neck Surgery, 2008
- Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infectionJournal of the American Academy of Dermatology, 2006
- Treatment of verruca vulgaris with topical cidofovir in an immunocompromised patient: a case report and review of the literatureTransplant Infectious Disease, 2005
- Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpoxPublished by Elsevier ,2005
- Management of acyclovir-resistant herpes simplex virusDermatologic Clinics, 2003
- Bioavailability and metabolism of cidofovir following topical administration to rabbitsAntiviral Research, 1997
- Pharmacokinetics of cidofovir in monkeys. Evidence for a prolonged elimination phase representing phosphorylated drug.1996
- Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats.1996